Skip to main content
. 1996 Dec 24;93(26):15346–15351. doi: 10.1073/pnas.93.26.15346

Table 1.

Pretransplant transduction efficiency

Patient no. Transduction sample no. Cancer type In situ PCR Plating efficiency Solution PCR
Without nesting With nesting
Suspension Suspension Suspension Suspension
O1 1 Ovary ND 2.0 + +
O2 2 Ovary ND 8.4 NE NE
O3 3 Ovary ND 5.7 +
O4 4 Ovary ND 16.5 ND +
O5 5 Ovary 3.0 5.7 ND +
O6 6 Ovary 1.2 20.1 +
O9 7 Ovary 1.9 6.0 + ND
B1 8 Breast ND 2.5 ND +
B2 9 Breast ND 18.1 +
B3 10 Breast 5.3 2.3 +
 Mean 2.8 8.7
  Median 1.9 5.7
Stromal Stromal Stromal Stromal
O7 1 Ovary 3.6 8.1 + ND
O8 2 Ovary 1.8 9.4 + ND
O10 3 Ovary 8.1 2.1 + ND
B4 4 Breast 6.9 −0.22 + ND
B5 5 Breast 9.0 14.7 + ND
B6 6 Breast 3.0 4.3 + ND
B7 7 Breast 2.5 2.2 + ND
B8 8 Breast 8.9 2.7 + ND
B9 9 Breast 3.7 1.0 + ND
B10 10 Breast 6.1 1.0 + ND
 Mean 5.4 4.5
  Median 6.1 2.7

The method of transduction (suspension or stromal) is indicated above each column of data. ND, not done; NE, not evaluable.